These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26895308)

  • 21. Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.
    Thomas R; Davies C; Nunez A; Hibbs S; Flick-Smith H; Eastaugh L; Smither S; Gates A; Oyston P; Atkins T; Eley S
    J Med Microbiol; 2010 Dec; 59(Pt 12):1415-1427. PubMed ID: 20798216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis).
    Vasconcelos D; Barnewall R; Babin M; Hunt R; Estep J; Nielsen C; Carnes R; Carney J
    Lab Invest; 2003 Aug; 83(8):1201-9. PubMed ID: 12920249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling particle deposition in the Balb/c mouse respiratory tract.
    Winkler-Heil R; Hofmann W
    Inhal Toxicol; 2016; 28(4):180-91. PubMed ID: 26986953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.
    Coleman ME; Marks HM; Bartrand TA; Donahue DW; Hines SA; Comer JE; Taft SC
    Risk Anal; 2017 May; 37(5):943-957. PubMed ID: 28121020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive models for deposition of inhaled diesel exhaust particles in humans and laboratory species.
    Yu CP; Xu GB
    Res Rep Health Eff Inst; 1987; (10):3-22. PubMed ID: 2478161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
    Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax.
    Hilliard JJ; Jakielaszek C; Mannino F; Hossain M; Qian L; Fishman C; Demons S; Hershfield J; Soffler C; Russo R; Henning L; Novak J; O'Dwyer K
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0149723. PubMed ID: 38358266
    [No Abstract]   [Full Text] [Related]  

  • 29. Modeling age-related particle deposition in humans.
    Asgharian B; Ménache MG; Miller FJ
    J Aerosol Med; 2004; 17(3):213-24. PubMed ID: 15625813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
    Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
    Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats.
    Asgharian B; Kelly JT; Tewksbury EW
    Toxicol Sci; 2003 Jan; 71(1):104-11. PubMed ID: 12520080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulation and minimisation of the airway deposition of airborne bacteria.
    Balásházy I; Horváth A; Sárkány Z; Farkas A; Hofmann W
    Inhal Toxicol; 2009 Oct; 21(12):1021-9. PubMed ID: 19772481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of regional deposition dosage for inhaled nanoparticles in human and rat olfactory.
    Tian L; Shang Y; Chen R; Bai R; Chen C; Inthavong K; Tu J
    Part Fibre Toxicol; 2019 Jan; 16(1):6. PubMed ID: 30683122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures.
    Hofemeier P; Koshiyama K; Wada S; Sznitman J
    Eur J Pharm Sci; 2018 Feb; 113():53-63. PubMed ID: 28954217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.
    Yee SB; Dyer DN; Twenhafel NA; Pitt ML
    Comp Med; 2013 Jun; 63(3):252-61. PubMed ID: 23759528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS).
    Morgan DL
    Toxic Rep Ser; 2006 Aug; (74):1-62, A1-C2. PubMed ID: 17160106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.